Skip to main content

COVID-19 vaccines and cancer: Health professional guidance

Australia & New Zealand

Australasian Society of Clinical Immunology and Allergy
Allergy, Immunodeficiency, Autoimmunity and COVID-19 Vaccination Position Statement
Date: 14-Apr-2021
Audience: Health professionals
Purpose: Guidance for healthcare providers and public health officials on the COVID-19 vaccine, including considerations for vaccination of immunocompromised people.

Medical Oncology Group of Australia (MOGA)
COVID-19 vaccination in patients with solid tumours position statement
Date: 13-Apr-2021
Audience: Medical oncologists and other health professionals
Purpose: Position statement for cancer clinicians and other healthcare professionals caring for people with cancer in relation to the COVID-19 vaccine.

Queensland Health
COVID-19 vaccination advice for cancer patients
Date: 01-Apr-2021
Audience: Health professionals
Purpose: Guidance on the COVID-19 vaccine for clinicians and their cancer patients.

The Royal Australian and New Zealand College of Radiologists (RANZCR)
The Royal Australian and New Zealand College of Radiologists Statement on Vaccine Induced Adenopathy
Date: 24-Mar-2021
Audience: Radiologists
Purpose: Guidance on vaccine induced adenopathy for cancer patients.

Haematology Society of Australia and New Zealand
COVID-19 Vaccination in Haematology Patients: An Australia and New Zealand Consensus Position Statement
Date: 02-Feb-2021
Audience: Haematologists and other health professionals
Purpose: Guidance on the COVID-19 vaccine for Haematology patients.

Australia and New Zealand Transplant and Cellular Therapies 
Australia and New Zealand Transplant and Cellular Therapies COVID19 Vaccination Consensus Position Statement
Date: 20-Jan-2021
Audience: Haematologists and other health professionals
Purpose: Guidance on the COVID-19 vaccine for haematopoietic stem cell transplant and CAR-T cell (TCT) patients.

UK

Blood Cancer UK
Covid vaccine and blood cancer
Date: 30-Apr-2021
Audience: Health professionals
Purpose: Blog on the latest research and evidence in the area of the COVID-19 vaccine and blood cancer.

British Lymphology Society
Consensus document on COVID-19 vaccination for patients with lymphoedema
Date: 15-Feb-2021
Audience: Health professionals
Purpose: Consensus recommendations regarding COVID-19 vaccination for patients with lymphoedema:

UK Chemotherapy Board
Clinician Frequently Asked Questions (FAQs) and guidance on COVID-19 vaccine for patients receiving Systemic Anti-Cancer Therapy
Date: 09-Feb-2021
Audience: Medical oncologists and other health professionals
Purpose: Guidance on the COVID-19 vaccine for patients receiving systemic anti-cancer therapy.

USA

American Society of Clinical Oncology
COVID-19 Vaccine & Patients with Cancer
Date: 19-Mar-2021
Audience: Health professionals
Purpose: Q&A on the COVID-19 vaccine and its impact on patients with cancer.

National Comprehensive Cancer Network
Recommendations of the NCCN COVID-19 Vaccination Advisory Committee
Date: 10-Mar-2021
Audience: Oncology health professionals
Purpose: Guidance for COVID-19 vaccinations in people with cancer.

Centres for Disease Control and Prevention
Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Authorized in the United States
Date: 05-Mar-2021
Audience: Health professionals
Purpose: Guidance for healthcare providers and public health officials on the COVID-19 vaccine, including considerations for vaccination of immunocompromised people.

North American Neuroendocrine Tumor Society
NANETS’ Position Statement COVID-19 Vaccination for NEN patients
Date: 01-Feb-2021
Audience: Health professionals
Purpose: Position statement on the COVID-19 vaccine for patients with neuroendocrine neoplasms.

American Society for Radiation Oncology
ASTRO Recommendation on COVID-19 Vaccination for Cancer Patients Receiving Radiation Therapy
Date: 26-Jan-2021
Audience: Radiation oncology professionals
Purpose: Recommendation on the COVID-19 vaccine for cancer patients receiving radiation therapy.

Europe

French Society for Immunotherapy of Cancer (FITC)
SARS-CoV-2 vaccines for cancer patients treated with immunotherapies: Recommendations from the French society for Immuno-Therapy of Cancer (FITC)
Date: 18-Feb-2021
Audience: Medical oncologists and other health professionals
Purpose: Recommendations on the COVID-19 vaccine for cancer patients treated with immunotherapy.

European Society for Medical Oncology (ESMO)
COVID-19 vaccination in patients with cancer: ESMO releases ten statements
Date: 22-Dec-2020
Audience: Medical oncologists and other health professionals
Purpose: Statements on the efficacy and safety of the COVID-19 vaccine in relation to cancer patients.

Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)
Guideline on evidence-based management of COVID-19 in cancer patients regarding diagnostics, viral shedding, vaccination and therapy
Date: 10-Feb-2021
Audience: Haematologists, medical oncologists and other health professionals
Purpose: Evidence-based recommendations for rapid diagnostics, viral shedding, vaccination and therapy of COVID-19 in cancer patients.

International

International Society of Geriatric Oncology
The SIOG COVID-19 working group recommendations on the rollout of COVID-19 vaccines among older adults with cancer
Date: 05-Mar-2021
Audience: Haematologists, medical oncologists and other health professionals
Purpose: Recommendations on the rollout of COVID-19 vaccines for older patients with cancer.